Using advanced imaging technology to more precisely target radiation beams to treat soft tissue cancers (sarcomas) in the extremities significantly reduces long term side effects without effecting survival rates, according to research results published online today in the Journal of Clinical Oncology.
An international research team led by physician-scientists at Rush University Medical Center have gained new insights into hypothyroidism – a condition affecting about 10 million people in the U.S. – that may lead to new treatment protocols for the disease, particularly among the approximately 15 percent of patients for whom standard treatments are less effective.
NIH-funded collaboration on treatments of rare genetic syndromes that could reveal a shared biology of autism spectrum disorders
Two members of the Rush Alzheimer’s Disease Center have been included in a new listing of the most influential researchers in the world. David Bennett, MD, and Julie Schneider, MD, are among “The World’s Most Influential Scientific Minds 2014,” a roster compiled by Thompson Reuters, a global media and information company.
Rush Health has expanded its network with the addition of Riverside Medical Center, which joined Rush Health at the beginning of September. Rush Health is a clinically integrated network of hospitals, physicians and other clinicians. Riverside Medical Center is a 325-bed hospital based in Kankakee that employs approximately 57 doctors and 35 non-physician clinicians, who also have joined Rush Health.
Rush University Medical Center has received the UHC’s (University HealthSystem Consortium) Quality Leadership Award, ranking fifth among 104 academic medical centers in the UHC’s annual study. Rush is the only medical center in Illinois to be listed among the 12 top ranking medical centers.
Leading researchers, funded through a new, five-year, $3.2 million grant from the National Institutes of Health (NIH), are collaborating to develop and evaluate tests designed to measure and track changes in the cognitive functioning of people who typically are difficult to assess accurately: those with an intellectual disability, formerly termed mental retardation.
Researchers at UC San Francisco and Rush University Medical Center, Chicago, may have found a predictor for a disorder affecting kidney transplant recipients that can accelerate organ failure, a discovery that eventually could allow for customized therapies and improved patient selection for transplant.
Preventive medicine experts at Rush University Medical Center and Canyon Ranch Institute have teamed up to design and test a new program that tracks what students are actually choosing to eat at school meals and supports parents and caregivers in helping their child achieve a healthy lifestyle. The program is called, “Healthy School Meals Realized through Technology (SMART) Schools.”
A new study by neuropsychiatric researchers at Rush University Medical Center gives insight into the relationship between depression and dementia.
Rush University Medical Center once again has been named one of the nation’s top hospitals, according to the new issue of U.S. News & World Report. Rush is ranked in seven of 16 categories.
Rush University Medical Center has been named one of only 20, advanced “Most Wired” hospitals in the nation, according to the 16th annual survey conducted by Hospitals & Health Networks.
Neurological scientists at Rush University Medical Center have found that using cinnamon, a common food spice and flavoring material, can reverse the biomechanical, cellular and anatomical changes that occur in the brains of mice with Parkinson’s disease (PD).
Women with early-stage breast cancer may now receive a one-dose radiation treatment at the same time as lumpectomy surgery, eliminating the need to return to the hospital daily for up to six weeks for post surgical radiation treatments.
A new research study at Rush University Medical Center and Northwestern Medicine is testing whether a new investigational treatment can slow the memory loss caused by Alzheimer’s disease.
A disruption of circadian rhythms, when combined with a high-fat, high-sugar diet, may contribute to inflammatory bowel disease and other harmful conditions, according to a recent study conducted by researchers at Rush University Medical Center.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
(CHICAGO)—Urologists at Rush University Medical Center are the first in Chicago to offer a powerful new tool for visualizing and monitoring the prostate in men who have high prostate-specific antigen (PSA) levels and in detecting prostate cancer more accurately.
A new study by researchers at Rush University Medical Center reviews research that suggests that the risk for developing Alzheimer’s disease among older African Americans may be two to three times greater than in the non-Hispanic white population and that they differ from the non-Hispanic white population in risk factors and disease manifestation. The study results will be published in the April 7 issue of Health Affairs.
Infections caused by a specific type of antibiotic-resistant bacteria are on the rise in U.S. children, according to new study published in the Journal of the Pediatric Infectious Diseases Society. While still rare, the bacteria are increasingly found in children of all ages, especially those 1-5 years old, raising concerns about dwindling treatment options.
Dr. Antonio Bianco, a physician scientist working in the thyroid field, has joined Rush University Medical Center as professor of medicine, senior vice chair in the Department of Internal Medicine and division chief of endocrinology at Rush University Medical Center effective February 3rd.
Rush University Medical Center dedicates the opening of the city of Chicago's, newest, advanced, state-of-the-art facility for women and infants.
A newly-developed, “designer” dietary fiber with an added potential prebiotic effect may eliminate the side effects of current treatment for Irritable Bowel Syndrome (IBS) which affects 10-20 percent of the population, disproportionately women.
Recognizing the needs of Chicago area veterans like Ken, Rush University Medical Center developed a program to train military veterans in key health care IT technologies in order to jump start their careers.
Although there are several risk factors of dementia, abnormal fat metabolism has been known to pose a risk for memory and learning. People with high amounts of abdominal fat in their middle age are 3.6 times as likely to develop memory loss and dementia later in their life.
The results of a new study by bone and joint experts at Rush University Medical Center suggest that patients with knee osteoarthritis (OA) who wear flat, flexible footwear, which allows natural foot mobility and provide sufficient support for the foot, had significant reduction in knee loading—the force placed upon the joint during daily activities.
The National Institutes of Health announced on Wednesday the award of a new research grant to discover, characterize and validate complex molecular networks and candidate genes that influence susceptibility to cognitive decline and Alzheimer’s disease. The grant includes an effort to accelerate the translation of these discoveries into novel treatments.
In the Mexican American Trial of Community Health Workers (MATCH) study, participants visited in their homes by community health workers showed significant improvement in controlling their Type 2 diabetes.
The results of a new study by neurological researchers at Rush University Medical Center show that a sudden decrease of testosterone, the male sex hormone, may cause Parkinson’s like symptoms in male mice.
Researchers at Rush University Medical Center in Chicago, IL and The University of Illinois at Chicago are using the Internet and motivational multimedia coupled with positive reinforcement via a smartphone application to try to improve asthma outcomes among low-income, minority adolescents with asthma.
Using germ-killing soap and ointment on all intensive-care unit (ICU) patients can reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in ICUs, according study results published in today’s New England Journal of Medicine.
Older adults who are subject to elder abuse, neglect and exploitation face a greater risk of being hospitalized than other seniors, according to the results of a study published in the April 8 issue of JAMA Internal Medicine.
A promising new treatment for deadly brain tumors taken orally with minimal side effects is being studied by neurological researchers at Rush University Medical Center, Chicago. Rush is the first and only site in the world using the new drug treatment for deadly brain tumors.
Studies in mice with Alzheimer’s disease (AD) have shown that sodium phenylbutyrate, known as Buphenyl, successfully increases factors for neuronal growth and protects learning and memory, according to neurological researchers at the Rush University Medical Center.
Rush University Medical Center researchers participated in clinical trials for promising new drug against aggressive breast cancer called Kadcyla also known as TDM-1 (traztuzumab emtansine).
Surgeons at Rush University Medical Center have removed the kidney from a living-donor using a single incision in the navel, introducing to Illinois a cutting-edge surgical technique that can motivate more individuals to donate organs. The operation was performed on January 30, and both donor (daughter) and recipient (mother) have recovered and are home.
The number of people with Alzheimer’s disease is expected to triple in the next 40 years, according to a new study by researchers from Rush University Medical Center published in the February 6, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.
Feeding human breast milk to very-low-birth-weight infants greatly reduces risk for sepsis and significantly lowers associated neonatal intensive care unit (NICU) costs, according to a study by Rush University Medical Center researchers.
Rush University Medical Center is conducting the nation’s first clinical study of an innovative stem cell drug, Cartistem, to repair knee cartilage damaged by aging, trauma or degenerative diseases such as osteoarthritis.
Researchers at Rush University Medical Center, in collaboration with researchers at Northwestern University, have identified a molecular mechanism central to the development of osteoarthritis (OA) pain, a finding that could have major implications for future treatment of this often-debilitating condition.
People who sometimes went hungry as children had slower cognitive decline once they were elderly compared to people who always had enough food to eat, according to a new study by neurological researchers from the Rush Alzheimer’s Disease Center at Rush University Medical Center.
The Chicago region’s first comprehensive center serving patients from childhood into young adulthood with autism spectrum disorders has been established at Rush University Medical Center.
New Chicago adult congenital heart network holds first conference to address lack of adequate adult care for congenital heart defect patients.
Study explores psychosocial implications related to relationships, marriage and childbearing.
Regular mammography screening can help narrow the breast cancer gap between black and white women, according to a retrospective study published in Breast Cancer Research and Treatment in August.
The results from a new study by neurological researchers from the Rush Alzheimer’s Disease Center at Rush University Medical Center suggest that people who were emotionally neglected as children may have a higher risk of stroke in later adulthood.
The purpose of the Princeton III meeting was to find an approach for optimizing sexual function and preserving cardiovascular health in men with known cardiovascular disease and to develop a primary approach to cardiovascular risk assessment in younger men with erectile dysfunction and no cardiovascular disease. The conference updated findings from the Princeton I and Princeton II meetings, held in 2000 and 2005, respectively.
The Coleman Foundation awarded a grant of more than $542,000 to support a program aimed at making palliative care more accessible to patients facing cancer and other life-threatening illnesses. The grant will be administered by Rush and will support the Chicagoland Palliative Medicine Physician Collective to develop the “Primary Palliative Care Education Program to Improve Access to Palliative Care for Patients with Cancer.”
Rush is one of only five hospitals in the nation that the survey has ranked as a leader for four or more consecutive years, and one of only three in Illinois that met all of the survey’s main criterion this year.
The Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP) has awarded Rush University Medical Center full accreditation for the next three years. Rush is one of the first academic medical centers in Illinois to receive the accreditation.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right